journal
Journals Therapeutic Advances in Infect...

Therapeutic Advances in Infectious Disease

https://read.qxmd.com/read/38152611/respiratory-morbidity-in-schistosoma-mansoni-infection-a-rapid-review-of-literature
#21
REVIEW
Joseph Baruch Baluku, Ronald Olum, Richard E Sanya, Ponsiano Ocama
BACKGROUND: Schistosomiasis contributes to 2.5 million disability-adjusted life years globally. Acute and chronic respiratory morbidity of Schistosoma mansoni ( S. mansoni ) is poorly documented in the literature. We conducted a rapid literature review of the burden of respiratory symptoms and lung function abnormalities among patients with S. mansoni. We also report the immunologic and lung imaging findings from the studies reviewed. METHODS: We carried out a comprehensive literature search in Embase and MEDLINE from the inception of the databases to 13th March 2023...
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/38145193/diagnostic-accuracy-of-two-confirmatory-tests-for-diabetes-mellitus-in-adult-ugandans-with-recently-diagnosed-tuberculosis
#22
JOURNAL ARTICLE
Davis Kibirige, Stella Zawedde-Muyanja, Irene Andia-Biraro, Ronald Olum, Susan Adakun, Christine Sekaggya-Wiltshire, Ivan Kimuli
OBJECTIVE: The optimal confirmatory tests for diabetes mellitus (DM) in patients with tuberculosis (TB) vary across populations. This study aimed to evaluate the performance of two confirmatory tests for DM against the oral glucose tolerance test (OGTT) as the reference test in adult Ugandans with recently diagnosed TB. METHODS: A total of 232 adult participants receiving TB treatment underwent initial screening for DM with random blood glucose (RBG) measurement...
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/38145192/a-retrospective-study-on-the-status-of-sexually-transmitted-co-infections-in-university-hospitals-in-korea-from-2017-to-2021
#23
JOURNAL ARTICLE
Sun Jung Lee, Tae Su Jang, Jae Kyung Kim
BACKGROUND: The prevalence of sexually transmitted infections (STIs) remains high worldwide. Despite the worldwide increase in the incidence of STIs every year, there are few reports on the frequency of STIs with different pathogens according to age and gender. Accordingly, a study was conducted to determine trends in co-infection with STIs by age and gender in Cheonan, South Korea from 2017 to 2021. OBJECTIVES: To identify trends by age or sex in co-infection of STIs in this region...
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/38127471/best-practices-implementation-and-challenges-of-outpatient-parenteral-antimicrobial-therapy-results-of-a-worldwide-survey-among-healthcare-providers
#24
JOURNAL ARTICLE
Moska Hassanzai, Fadime Adanç, Birgit Koch, Nelianne Verkaik, Jakob van Oldenrijk, Jorg de Bruin, Brenda de Winter, Hein van Onzenoort
BACKGROUND: Outpatient Parenteral Antimicrobial Therapy (OPAT) is considered a patient-friendly and cost-effective practice. Patients in the OPAT service can be at risk for developing adverse events. Due to extensive variations in practice, guidelines have been developed to minimize the risks. OBJECTIVES: In this first worldwide survey on OPAT, we explored the current OPAT services around the world, adherence to recommendations and identified best practices and challenges from different perspectives...
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/38116297/unveiling-the-hungarian-landscape-of-laboratory-and-clinical-management-capacities-for-invasive-fungal-infections-navigating-the-frontlines-against-fungal-menaces
#25
JOURNAL ARTICLE
Renátó Kovács, László Majoros, Jannik Stemler, Oliver Andreas Cornely, Jon Salmanton-García
BACKGROUND: Antifungal diagnostic capacity has been documented in various countries, there is a lack of comprehensive research on clinical mycology diagnostics and treatment in Hungary. METHODS: We conducted an online survey encompassing questions that explored various aspects of the mycology diagnostic and antifungal therapy-related information. The survey aimed to gather details about institutional profiles, perceptions of invasive fungal infections (IFIs), and access to microscopy, culture, serology, antigen detection, molecular testing, and therapeutic drug monitoring...
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/38107553/covid-19-vaccine-acceptance-in-the-second-wave-of-the-pandemic-among-university-students-in-ethiopia-application-of-the-health-belief-model
#26
JOURNAL ARTICLE
Befkad Derese Tilahun, Tiruneh Adane, Molla Fentanew, Tilahun Dessie Alene, Gebremeskel Kibret Abebe, Habtamu Setegn Ngusie
BACKGROUND: The first case of COVID-19 virus was reported in Africa on 14 February 2020. The pandemic became more aggressive in the continent during the second wave than the first wave. Promoting vaccination behavior is an unparalleled measure to curb the spread of the pandemic. Regarding this, the health belief model (HBM) is the major model for understanding health behaviors. This study aimed to examine predictors of intended COVID-19 vaccine acceptance in the second wave of the pandemic among university students in Ethiopia using HBM...
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/38107552/practical-dosing-guidance-for-the-management-of-clinician-administered-injections-of-long-acting-cabotegravir-and-rilpivirine
#27
REVIEW
Parul Patel, Paula Teichner, Emilie Elliot, Marta Boffito, Milena Murray, Joseph W Polli, Mark Baker, Susan L Ford, Kelong Han, Alberto Russu, Herta Crauwels, Ronald D D'Amico, William R Spreen, Jean van Wyk
Cabotegravir (CAB) and rilpivirine (RPV) is the first complete long-acting (LA) injectable regimen recommended by treatment guidelines for the maintenance of HIV-1 virologic suppression in people with HIV-1 who are virologically suppressed on a stable antiretroviral regimen that is administered monthly (Q1M) or every 2 months (Q2M). As an alternative regimen to lifelong daily oral antiretroviral therapy, Q1M or Q2M dosing schedules are associated with increased patient satisfaction and treatment preference...
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/38090135/recent-meningitis-outbreak-in-iraq-a-looming-threat-to-public-health
#28
JOURNAL ARTICLE
Karzan Qurbani, Safin Hussein, Sirwan Khalid Ahmed
No abstract text is available yet for this article.
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/38074945/environmental-health-and-infectious-diseases-challenges-and-perspectives-in-latin-america
#29
JOURNAL ARTICLE
Gabriel Parra-Henao, Enrique Henao, Jose Pablo Escobar
No abstract text is available yet for this article.
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/38029068/global-evaluation-of-the-antibacterial-activity-of-ceftolozane-tazobactam-against-esbls-producing-escherichia-coli-and-klebsiella-pneumoniae-a-systematic-review-and-meta-analysis
#30
JOURNAL ARTICLE
Marzieh Rahim Khorasani, Soodabeh Rostami, Arash Bakhshi, Raheleh Sheikhi
BACKGROUND: Ceftolozane/Tazobactam is a β-lactam/β-lactamase inhibitor combination with a high range of efficacy and broad-spectrum action against multidrug-resistant bacterial strains. OBJECTIVES: The present study aimed to analyze the in vitro activity of Ceftolozane/Tazobactam against extended-spectrum β-lactamases (ESBLs)-producing Escherichia coli (ESBLs-EC) and Klebsiella pneumonia (ESBLs-KP) in the published literature to provide international data on the antimicrobial stewardship programs...
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/37954406/clinical-characteristics-and-use-of-antibiotics-in-a-group-of-patients-with-snake-bites-in-colombia
#31
JOURNAL ARTICLE
Luis Fernando Valladales-Restrepo, Ana Sofia Rojas-Ramirez, Melba Jasbleidy Santander-Pai, Valeria Lozada-Castaño, Laura Valentina Bedoya-Duque, Dayana Yuliet Sabogal-Sanchez, Nicolas Stiven Gómez-Gómez, Jorge Enrique Machado-Alba
INTRODUCTION: Millions of snake bites occur worldwide each year. Clinical practice guidelines generally do not recommend the use of prophylactic antibiotics. OBJECTIVE: To determine the sociodemographic, clinical, and pharmacological variables and the use of antibiotics in a group of patients with snake bites in Colombia. METHODS: A retrospective cross-sectional study was carried out. Patients affiliated with a Colombian health insurer who presented with snake bites between 2015 and 2022 were included...
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/37954405/facilitating-opat-in-rural-areas
#32
REVIEW
Meera Mehta, Molly Benning, Jessica E Johnson, Keenan L Ryan
A sizable portion of the United States' population lives in a rural setting. Coupled with a limited number of infectious diseases providers, this has created a need for innovative practice models to deliver outpatient antimicrobial therapy and clinical monitoring in rural settings. This article reviews existing literature regarding outpatient parenteral antimicrobial therapy in rural settings and explores existing barriers and potential solutions that may be of assistance to providers looking to provide these services...
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/37954404/association-between-hepatitis-b-or-hepatitis-c-virus-infection-and-risk-of-pancreatic-cancer-a-systematic-review-and-meta-analysis-of-cohort-studies
#33
JOURNAL ARTICLE
Jian-Feng Zhao, Qiu-Ping Teng, Yang Lv, Xiao-Yi Li, Yi Ding
BACKGROUND AND AIM: With conflicting data from previous observational studies on the relationship between hepatitis B virus (HBV) or hepatitis C virus (HCV) infection and pancreatic cancer (PC), we decided to conduct a systematic review and meta-analysis in order to evaluate any potential association. DESIGN: This is a systematic review and meta-analysis. METHODS: We conducted a search of three databases (PubMed, Embase, and Web of Science) from the time of their creation up to June 2023...
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/37954403/acceptability-rate-and-barriers-to-covid-19-vaccination-among-healthcare-workers-in-chukwuemeka-odumegwu-ojukwu-university-teaching-hospital-amaku-awka-nigeria
#34
JOURNAL ARTICLE
Ngozi Nneka Joe-Ikechebelu, Uche Marian Umeh, George Uchenna Eleje, Emeka Philip Igbodike, Emmanuel Okwudili Ogbuefi, Angela Oyilieze Akanwa, Sylvia Tochukwu Echendu, Williams Onyeka Ngene, Augusta Nkiruka Okpala, Onyinye Chigozie Okolo, Chidubem Ekpereamaka Okechukwu, Josephat Chukwudi Akabuike, Helen Obioma Agu, Vincent Ogochukwu Okpala, Onyinye Chinenye Nwazor, Anthony Obiajulu Ugochukwu Nnedum, Chinyere Celestina Esimone, Hephzibah Ngozi Agwaniru, Ethel Ifeoma Ezeabasili, Belusochi Blessing Joe-Ikechebelu
BACKGROUND: Healthcare workers were at the forefront of the COVID-19 pandemic. The acceptability and uptake of COVID-19 vaccines among healthcare workers was an important strategy in halting the spread of the virus as well as the antecedent implications on global health and the world economy. OBJECTIVES: This study aims to determine the acceptability rate and barriers to COVID-19 vaccination of frontline healthcare workers in Awka, Nigeria. DESIGN: This is an analytical cross-sectional study...
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/37915499/antileishmanial-activity-of-5-nitroindazole-derivatives
#35
JOURNAL ARTICLE
Niurka Mollineda-Diogo, Claudia Sissely Chaviano-Montes de Oca, Sergio Sifontes-Rodríguez, Teresa Espinosa-Buitrago, Lianet Monzote-Fidalgo, Alfredo Meneses-Marcel, Aliuska Morales-Helguera, Yunierkis Perez-Castillo, Vicente Arán-Redó
BACKGROUND: Currently, there is no safe and effective vaccine against leishmaniasis and existing therapies are inadequate due to high toxicity, cost and decreased efficacy caused by the emergence of resistant parasite strains. Some indazole derivatives have shown in vitro and in vivo activity against Trichomonas vaginalis and Trypanosoma cruzi . On that basis, 20 indazole derivatives were tested in vitro against Leishmania amazonensis . OBJECTIVE: To evaluate the in vitro activity of twenty 2-benzyl-5-nitroindazolin-3-one derivatives against L...
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/37900982/intention-to-use-prep-among-men-who-have-sex-with-men-and-engage-in-chemsex-an-international-descriptive-study
#36
JOURNAL ARTICLE
Álvaro Francisco Lopes de Sousa, Caíque Jordan Nunes Ribeiro, Guilherme Reis de Santana Santos, Layze Braz de Oliveira, Emerson Lucas Silva Camargo, Shirley Verônica Melo Almeida Lima, Inara Viviane de Oliveira Sena, Márcio Bezerra-Santos, Odinéa Maria Amorim Batista, Anderson Reis de Sousa, Isabel Amélia Costa Mendes
BACKGROUND: Pre-exposure prophylaxis (PrEP) is a valuable tool in the response to the HIV epidemic, recommended for groups with a higher risk of HIV infection, such as men who have sex with men (MSM), particularly in the context of high-risk sexual behavior such as chemsex. PURPOSE: This study aimed to analyze the prevalence and factors associated with the intention to use PrEP among MSM who engage in chemsex in Brazil and Portugal. METHODS: This was a cross-sectional study of a secondary dataset from a larger study conducted between January 2020 and May 2021 throughout Brazil and Portugal involving 1852 MSM who engage in chemsex...
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/37869469/bacterial-bloodstream-infection-in-critically-ill-patients-with-covid-19-a-retrospective-cohort-study
#37
JOURNAL ARTICLE
Mateusz Bartoszewicz, Sławomir Lech Czaban, Klaudia Bartoszewicz, Damian Kuźmiuk, Jerzy Robert Ładny
BACKGROUND: Intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19), have a high risk of developing bloodstream infections (BSIs). However, the characteristics of and risk factors for BSIs in these patients remain unclear. OBJECTIVE: We aimed to identify prevalent causative pathogens of BSI and related factors in critically ill patients with COVID-19. DESIGN: This was a single-center, retrospective cohort study. METHODS: We analyzed the clinical characteristics and outcomes of 201 ICU patients with COVID-19...
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/37842170/recent-nipah-virus-outbreak-in-india-lessons-and-imperatives
#38
EDITORIAL
Shriyansh Srivastava, Novonil Deb, Poulami Roy, Vikash Jaiswal, Sanjit Sah, Yogesh Pandey, Ravi Sankar Reddy Edara, Aroop Mohanty, Andrés F Henao-Martínez, Ranjit Sah
No abstract text is available yet for this article.
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/37842169/what-is-the-role-of-the-clinical-microbiology-laboratory-in-the-care-of-diagnostically-challenging-opat-patients-illustrative-cases-and-literature-review
#39
REVIEW
Priya Nori, Phyu Thwe, Jaime Mogollon, Rachel Bartash, Wendy Szymczak, Erika Orner, Musa Bolkent, Robin Patel
Optimal care of patients requiring long-term outpatient parenteral or oral antimicrobial therapy by infectious diseases (ID) specialists is facilitated by an accurate microbiologic diagnosis. Close collaboration between ID specialists and the clinical microbiology laboratory for routine or specialized molecular testing can result in more accurate diagnoses, streamlined antimicrobial regimens, and improved patient outcomes.
2023: Therapeutic Advances in Infectious Disease
https://read.qxmd.com/read/37779674/population-based-assessment-of-the-burden-of-covid-19-infection-in-african-countries-a-first-year-report-card-and-public-health-implications
#40
JOURNAL ARTICLE
Osaro Mgbere, Ogbonna Collins Nwabuko, Olajumoke A Olateju, Omolola E Adepoju, Winston Liaw, Charles Darkoh, Ekere James Essien
BACKGROUND: The COVID-19 pandemic constitutes a global health threat and poses a major burden on the African continent. We assessed the real-world burden of COVID-19 infection in African Union (AU) member states to determine the distributional patterns of epidemiological measures during the first 1 year of the pandemic. METHODS: This retrospective cross-sectional study utilized COVID-19 data from publicly available data repositories of the African Center for Disease Control and Prevention and Our World in Data for the period February 2020 to January 2021...
2023: Therapeutic Advances in Infectious Disease
journal
journal
48580
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.